skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

4 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Real-World Evidence Sought In Sanofi Pasteur Observational Flu Vaccine Trial

Real-World Evidence Sought In Sanofi Pasteur Observational Flu Vaccine Trial

Vaccine maker Sanofi Pasteur and managed care group Kaiser Permanente have joined forces in an observational trial using electronic medical records from 1.6 million people to highlight the benefits of integrated big data.

Topic clinical-trials influenza-virus vaccines

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor...

December 2018 National Influenza Week

December 2018 National Influenza Week

3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

Topic influenza-virus infectious-diseases

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Not To Be Sniffed At: Dupixent Success In Rhinosinusitis Could Open Up Large Additional Market

Not To Be Sniffed At: Dupixent Success In Rhinosinusitis Could Open Up Large Additional Market

On the brink of an expanded US approval for asthma, Sanofi/Regeneron’s interleukin-4 receptor blocker Dupixent has produced positive topline Phase III data in a lucrative third indication, rhinosinusitis with nasal polyps.

Topic influenza-virus

Rising to the Challenge: An Analysis of the Influenza Vaccine Landscape in Response to the Swine Flu Pandemic

Rising to the Challenge: An Analysis of the Influenza Vaccine Landscape in Response to the Swine Flu Pandemic

The swine influenza pandemic in 2009/10 highlighted numerous challenges in providing effective influenza vaccine coverage.

Topic influenza-virus

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。